World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
29399
World Ranking
14514
National Ranking
1340

A. R. Norman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where A. R. Norman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 286 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

A. R. Norman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where A. R. Norman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

A. R. Norman is affiliated with the Royal Marsden NHS Foundation Trust in the United Kingdom. Their research spans fields related to psychology, economics, econometrics, finance, and health professions.

Their academic work covers several subfields, including economics and econometrics, general health professions, clinical psychology, developmental and educational psychology, and emergency medicine.

Norman's main research topics are diverse and include health systems, economic evaluations, quality of life, healthcare cost, quality and practices, pharmaceutical economics and policy, stuttering research and treatment, language development and disorders, reading and literacy development, as well as emergency and acute care studies.

Recent publications by Norman include the following:

  • Cost of Illness and Health-Related Quality of Life for Stuttering: Two Systematic Reviews, 2023, Journal of Speech Language and Hearing Research

Norman has collaborated frequently with several co-authors. These include Zachary Tirrell, Martin Hoyle, Sean Lybrand, Bonny Parkinson, and Robyn Lowe.

Their publications have appeared in multiple venues, among them:

  • Journal of Speech Language and Hearing Research
  • Frontiers in Psychiatry
  • PharmacoEconomics
  • Value in Health

Best Publications

  • Capecitabine and oxaliplatin for advanced esophagogastric cancer.

    David Cunningham;Alicia F C Okines;Sue Ashley

  • Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

    A Webb;D Cunningham;J H Scarffe;P Harper

  • Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study

    H. J. N. Andreyev;A. R. Norman;D. Cunningham;J. Oates

  • Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies

    H.J.N. Andreyev;A.R. Norman;J. Oates;D. Cunningham

  • Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

    David P Dearnaley;Vincent S Khoo;Andrew R Norman;Lesley Meyer

  • Kirsten ras Mutations in Patients With Colorectal Cancer: the Multicenter “RASCAL” Study

    H. J. N. Andreyev;A. R. Norman;D. Cunningham;J. R. Oates

  • Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data

    Ian Chau;Andy R. Norman;David Cunningham;Justin S. Waters

  • Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer

    P J Ross;Marianne Nicolson;David Cunningham;Juan W Valle

  • Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer

    R.A. Huddart;A. Norman;M. Shahidi;A. Horwich

  • Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer

    Ian Chau;Gina Brown;David Cunningham;Diana Tait

  • Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: Results of the MERCURY Study

    J. M Fowler;C. E Beagley;L Blomqvist;G Brown

  • Prognostic significance of magnetic resonance imaging‐detected extramural vascular invasion in rectal cancer

    N J Smith;Y Barbachano;A R Norman;R I Swift

  • Predicting Response of Colorectal Hepatic Metastasis: Value of Pretreatment Apparent Diffusion Coefficients

    Dow-Mu Koh;Erica Scurr;David Collins;Baris Kanber

  • Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial.

    J S Waters;A Norman;D Cunningham;J H Scarffe

  • Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours

    J. M. O’Sullivan;R. A. Huddart;A. R. Norman;J. Nicholls

  • Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.

    Roy Vergis;Catherine M Corbishley;Andrew R Norman;Jaclyn Bartlett

  • Adjuvant or Palliative Chemotherapy for Colorectal Cancer in Patients 70 Years or Older

    R. A. Popescu;A. Norman;P. J. Ross;B. Parikh

  • MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?

    S Burton;G Brown;I R Daniels;A R Norman

  • Fertility after chemotherapy for testicular germ cell cancers.

    H Lampe;A Horwich;A Norman;J Nicholls

  • A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)

    M. Findlay;D. Cunningham;A. Norman;J. Mansi

Frequent Co-Authors

David Cunningham
David Cunningham Royal Marsden NHS Foundation Trust
David P. Dearnaley
David P. Dearnaley Institute of Cancer Research
Alan Horwich
Alan Horwich Royal Marsden NHS Foundation Trust
Robert Huddart
Robert Huddart Institute of Cancer Research
Ian Chau
Ian Chau Royal Marsden NHS Foundation Trust
Gina Brown
Gina Brown Imperial College London
Vincent Khoo
Vincent Khoo Royal Marsden NHS Foundation Trust
Chris Parker
Chris Parker Institute of Cancer Research
Mary O'Brien
Mary O'Brien Royal Marsden NHS Foundation Trust
Rosalind A. Eeles
Rosalind A. Eeles Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees online can open up diverse career opportunities in medicine and patient care. For those seeking an advanced practice role, there are several cheap np programs available. These flexible programs are budget-friendly and can help you become a nurse practitioner without breaking the bank.

Starting your journey in nursing is also more accessible than ever, thanks to a range of nursing school online options. These programs are ideal for students who need to balance work and family commitments while pursuing a degree.

Looking to advance even further? Consider enrolling in online phd programs nursing. These doctoral offerings can support careers in research, teaching, and high-level clinical leadership.

If you're already a registered nurse, the cheapest rn to bsn pathways provide a cost-effective way to upgrade your credentials and potentially increase your earning power.

With so many online options, it's easier than ever to tailor your education to fit your goals and budget while advancing your medical career in the USA.

Best Scientists Citing A. R. Norman

Recently Published Articles